Belgian family confirms possible link between HLA-DRB1*11:01 and statin-induced myositis

In Belgium, a father and daughter :

  • developed autoimmune necrotising myopathy with HMGCR autoantibodies a few years apart, following treatment with statins;
  • are both carriers of HLA-DRB1*11:01, a variant already identified as being more frequent in this disease.

The case of this Belgian family strengthens the hypothesis of genetic susceptibility to autoimmune myositis. Investigation of the other members of this family could help identify other genetic predisposing factors and, in so doing, consider a preventive strategy, screening patients at risk before starting them on statins.

 

The first reported familial case of statin-induced immune-mediated necrotizing myopathy associated with anti-hydroxy-3-methylglutaryl-CoA reductase autoantibodies and HLA DRB1*11:01. Bronchain M, Pothen L, Taihi L et al. Acta Clin Belg. 2024 Sep 16:1-5.